Drug Profile
Research programme: CCR1 antagonists - Active Biotech
Alternative Names: CCR-1 project - Active BiotechLatest Information Update: 26 Feb 2009
Price :
$50
*
At a glance
- Originator Active Biotech
- Class
- Mechanism of Action CCR1 receptor antagonists; Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Autoimmune disorders; Inflammation
Most Recent Events
- 17 May 2006 Preclinical trials in Autoimmune disorders in Sweden (unspecified route)
- 17 May 2006 Preclinical trials in Inflammation in Sweden (unspecified route)